ACOX2 and breast carcinoma: Main strengths of our study include the use of multiple, independent methods to investigate COX2 specificity of four different αCOX2 antibody clones; the use of robust biochemical approaches to demonstrate dependency of S-nitrosylation state on COX2 antibody recognition; and the inclusion of over 2000 breast cancer cases to assess dual COX2 staining.